New Procedure for Treatment of Atrial Fibrillation in Patients with Valvular Heart Disease

New Procedure for Treatment of Atrial Fibrillation in Patients with Valvular Heart Disease

Show other versions (1)

"nPatients with valvular heart disease suffer from atrial fibrillation for more than 12 months after valve surgery and have a low probability of remaining in sinus rhythm. We performed an intra-operative procedure similar to surgical maze ІІІ procedure for conversion of this arrhythmia to s...

Full description

Bibliographic Details
Main Authors:	Naser Safaie, Nasrollah Maghamipour, Ahmad Reza Jodati, Ata Mahmoodpoor, Leila Dashtaki, Masoud Hakimzadeh
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2010-09-01
Series:	Acta Medica Iranica
Subjects:	Atria fibrillation Valvular disease Sinus rhythm operative procedureus
Online Access:	http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/16828.pdf&manuscript_id=16828

Similar Items

New Procedure for Treatment of Atrial Fibrillation in Patients with Valvular Heart Disease
by: Naser Safaie, et al.
Published: (2010-10-01)

INTRAOPERATIVE RADIOFREQUENCY AND CRYOABLATION FOR ATRIAL FIBRILLATION IN PATIENTS WITH VALVULAR HEART DISEASE
by: N. Maghamipour N. Safaie
Published: (2007-05-01)

INTRAOPERATIVE RADIOFREQUENCY AND CRYOABLATION FOR ATRIAL FIBRILLATION IN PATIENTS WITH VALVULAR HEART DISEASE
by: N. Maghamipour N. Safaie
Published: (2007-02-01)

Is There Association Between Changes in eGFR Value and the Risk of Permanent Type of Atrial Fibrillation? - Analysis of Valvular and Non-Valvular Atrial Fibrillation Population
by: Elzbieta Mlodawska, et al.
Published: (2014-12-01)

Sinus Rhythm Conduction Properties across Bachmann’s Bundle: Impact of Underlying Heart Disease and Atrial Fibrillation
by: Christophe P. Teuwen, et al.
Published: (2020-06-01)

Current strategies of anticoagulation therapy for patients with non-valvular atrial fibrillation
by: Masahiro Yasaka
Published: (2012-12-01)

Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
by: Athanasios Samaras, et al.
Published: (2021-09-01)

Structural and functional characteristics of myocard in patients with different forms of atrial fibrillation
by: L. I. Vasilyeva, et al.
Published: (2015-02-01)

Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation
by: Jason D. Bayer, et al.
Published: (2019-09-01)

Radiofrequency Ablation for Treatment of Atrial Fibrillation
by: Azin Alizadehasl, et al.
Published: (2011-09-01)

Role of miRNA in the development of atrial fibrillation in patients with valvular heart disease
by: I. V. Abdulyanov, et al.
Published: (2020-11-01)

The methods of treatment of atrial fibrillation in patients with valvular heart disease
by: O.M. Grytsay, et al.
Published: (2019-03-01)

Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
by: Faye L. Norby, et al.
Published: (2017-09-01)

FIBRILACIÓN AURICULAR EN EL PACIENTE HIPERTENSO. PAPEL DE LA AURÍCULA IZQUIERDA / Atrial fibrillation in hypertensive patients. Role of the left atrium
by: Elibet Chávez González
Published: (2011-03-01)

Huge Hiatal Hernia Mimicking a Mass with Compressive Effects on the Left Atrium Causing Paroxysmal Atrial Fibrillation
by: Murat Akçay, et al.
Published: (2019-03-01)

STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION. WHAT ROCKET AF STUDY RESULTS SAY
by: I. S. Yavelov
Published: (2017-11-01)

Comprehensive analysis of autophagy-related genes and patterns of immune cell infiltration in valvular atrial fibrillation
by: Ao Liu, et al.
Published: (2021-03-01)

A NORMAL BRADYSYSTOLIC FORM OF ATRIAL FIBRILLATION (FREDERICQ’S SYNDROME): LATE DIAGNOSIS AND TREATMENT
by: N. Ye. Trekina, et al.
Published: (2014-11-01)

A NORMAL BRADYSYSTOLIC FORM OF ATRIAL FIBRILLATION (FREDERICQ’S SYNDROME): LATE DIAGNOSIS AND TREATMENT
by: N. Ye. Trekina, et al.
Published: (2014-11-01)

Association of plasma fibronectin level with left atrial electrical and structural remodelling in lone paroxysmal atrial fibrillation: a cross-sectional study
by: Uğur Canpolat, et al.
Published: (2015-04-01)

Comparison of the Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Yasmin de Souza Lima Bitar, et al.
Published: (2021-09-01)

Gender-related differences in presentation and treatment of patients with non-valvular atrial fibrillation: results from RAMSES study
by: Volkan Doğan, et al.
Published: (2017-01-01)

Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study
by: Rungroj Krittayaphong, et al.
Published: (2018-08-01)

Comparing clinical outcomes of NOACs with warfarin on atrial fibrillation with Valvular heart diseases: a meta-analysis
by: Qiyu He, et al.
Published: (2019-05-01)

Use of Novel oral anticoagulants (NOACs) in patients with risk of stroke in non valvular Atrial Fibrillation (AF)
by: Fawad Farooq, et al.
Published: (2017-12-01)

Estimating the cost-effectiveness of treatment for prevention of thromboembolic events in at-risk adults with non-valvular atrial fibrillation
by: Marco Bellone, et al.
Published: (2018-02-01)

Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non-valvular atrial fibrillation
by: Daiki Shimomura, et al.
Published: (2015-08-01)

THE PREDICTION OF ATRIAL FIBRILLATION RECURRENCE AT VARIOUS METHODS OF SINUS RHYTHM RECOVERY
by: T. Y. Gromyko, et al.
Published: (2016-06-01)

A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation
by: Luxiang Shang, et al.
Published: (2021-07-01)

Approaches to anticoagulation therapy selection in patients with non-valvular atrial fibrillation and ischemic heart disease
by: N. A. Koziolova, et al.
Published: (2016-04-01)

Budget impact analysis of dabigatran compared with rivaroxaban in the prevention of the thromboembolic risk in patients with non-valvular atrial fibrillation
by: Maria Grazia Celeste, et al.
Published: (2017-11-01)

Paroxysmal Atrial Fibrillation: Dynamics of The Main Antioxidant Enzymes - Superoxide Dismutase and Catalase
by: Negreva Mariya N., et al.
Published: (2014-08-01)

Anticoagulation Therapy for Non-valvular Atrial Fibrillation: A Mini-Review
by: Jia Wu, et al.
Published: (2020-07-01)

Expression Profiles of Circular RNA in Human Atrial Fibrillation With Valvular Heart Diseases
by: Xiyu Zhu, et al.
Published: (2020-11-01)

Heart failure and atrial fibrillation: tachycardia‐mediated acute decompensation
by: Jin Joo Park, et al.
Published: (2021-08-01)

The relationship between polymorphisms of P-selectin genes and plasma P-selectin concentration with thrombosis in non-valvular atrial fibrillation of Kazakh ethnicity
by: Maerjiaen Bakeyi, et al.
Published: (2020-08-01)

Synaptic Plasticity in Cardiac Innervation and Its Potential Role in Atrial Fibrillation
by: Jesse L. Ashton, et al.
Published: (2018-03-01)

Modified Frailty as a Novel Factor in Predicting the Maintenance of the Sinus Rhythm After Electrical Cardioversion of Atrial Fibrillation in the Elderly Population
by: Mlynarska A, et al.
Published: (2020-07-01)

Increased levels of red cell distribution width is correlated with presence of left atrial stasis in patients with non-valvular atrial fibrillation
by: Adnan Kaya, et al.
Published: (2017-05-01)

Effect of single intraoperative dose of amiodarone in patients with rheumatic valvular heart disease and atrial fibrillation undergoing valve replacement surgery
by: Selvaraj Thiruvenkadam, et al.
Published: (2009-01-01)